6thWave: AI News Hub

The informed consent document (ICD), a crucial element in clinical trials, has remained stagnant in its design and content, leading to poor understanding among participants and compromised trial results. Despite the importance of ICDs being easy to understand and written in plain language, they have become excessively lengthy and complex. This article highlights the need for a paradigm shift in ICD design, emphasizing the importance of visual prompts, logical flow of information, and plain language. The FDA’s recent guidance on facilitating understanding in informed consent provides a much-needed push towards innovation. A multidisciplinary team, including patient representatives, investigators, and medical writers, should develop ICDs that cater to the specific needs of the patient population. While generative AI may be a useful tool, it should not replace human input and critical thinking in ICD development.

Source.